In the years since a 2005 study found that diabetes patients taking metformin had lower rates of cancer, oncologists have been excited by the prospect of using the inexpensive, safe, and widely used diabetes drug to prevent ...
Nov 6, 2023
0
2
Pancreatic cancer is not just one disease, but that's the way it is currently treated. New work from Tannishtha Reya's lab could help pave the way for a change. The research is published in the journal Cancer Cell.
Nov 6, 2023
0
27
A newly developed prediction model may be able to calculate the risk of opioid relapse among individuals in the early stages of medication treatment—as early as three weeks into therapy.
Nov 3, 2023
0
19
Chemotherapy is essential for many cancer patients, but some suffer from cognitive impairment throughout treatment. "Chemobrain" can consist of deficits in memory, attention, and executive function.
Oct 19, 2023
0
66
After an initial COVID infection, some adults may develop lingering symptoms that can last for weeks, months, or even years. There are many different types of symptoms people can experience, including fatigue and brain fog, ...
Oct 17, 2023
0
1
Cancer research has long focused on targeting the genetic mutations that drive tumors. Many of these genetic changes affect genes that allow mutated cells to replicate out of control. While developing drugs to target these ...
Oct 16, 2023
0
20
Does this sound like you? You wake up at the same time each morning, get the kids out the door, and rush to catch the subway to work. But at night, maybe you stay up until midnight doing laundry or 1 a.m. to catch up on the ...
Oct 13, 2023
0
94
In eastern Africa, malaria parasites have developed resistance to artemisinins, the backbone of current treatment regimens, a development that could dramatically worsen malaria's impact if partner drugs fail in the future.
Sep 27, 2023
0
35
Among today's obesity drugs, Wegovy (semaglutide) produces the greatest weight loss in teenagers, but a study by Columbia researchers has found that the trendy obesity drug is not cost-effective at its current price.
Sep 12, 2023
0
37
Paxlovid is still a highly effective treatment for most people infected with SARS-CoV-2 and the drug prevents many hospitalizations and deaths from COVID.
Sep 11, 2023
0
32
